K. Stanley

发表

Switch from ritonavir to indinavir in combination therapy for HIV-1-infected children.

C. Fletcher, S. Pelton, R. Yogev, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Combination nucleoside analog reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: week 24 results of a randomized controlled trial--PACTG 377. Pediatric AIDS Clinical Trials Group 377 Study Team.

S. Lee, P. Krogstad, S. Nachman, 2000, AIDS research and human retroviruses.

Immunologic response to combination nucleoside analogue plus protease inhibitor therapy in stable antiretroviral therapy-experienced human immunodeficiency virus-infected children.

S. Lee, W. Borkowsky, S. Douglas, 2000, The Journal of infectious diseases.

Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infection.

P. Krogstad, S. Nachman, H. Rosenblatt, 2005, The Journal of allergy and clinical immunology.

Evaluation of Randomized Controlled Trials

K. Stanley, 2007, Circulation.

A Behavioral and Cognitive Profile of Clinically Stable HIV-Infected Children

L. Mofenson, S. Pelton, R. Yogev, 2006, Pediatrics.

Prevalence and patterns of use of concomitant medications among participants in three multicenter human immunodeficiency virus type I clinical trials

P. Volberding, M. Fischl, R. Bassett, 1994 .

A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team.

J. McNamara, L. Mofenson, S. Spector, 1998, The Journal of pediatrics.

Combination and Monotherapy with Zidovudine and Zalcitabine in Patients with Advanced HIV Disease

Ann Collier, Judith Feinberg, A. Collier, 1995, Annals of Internal Medicine.

Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team.

S. Lee, W. Borkowsky, L. Mofenson, 2000, JAMA.

Growth in human immunodeficiency virus-infected children receiving ritonavir-containing antiretroviral therapy.

J. Lindsey, L. Mofenson, S. Pelton, 2002, Archives of pediatrics & adolescent medicine.

Immunological response to highly active antiretroviral therapy in children with clinically stable HIV-1 infection.

P. Krogstad, S. Nachman, H. Rosenblatt, 2005, The Journal of infectious diseases.

Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1.

P. Krogstad, S. Nachman, J. Mcnamara, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection.

E. Morse, P. Krogstad, S. Nachman, 2002, Pediatrics.

Growth of Human Immunodeficiency Virus-Infected Children Receiving Highly Active Antiretroviral Therapy

J. Lindsey, P. Krogstad, S. Nachman, 2005, The Pediatric infectious disease journal.

Nelfinavir pharmacokinetics in stable human immunodeficiency virus-positive children: Pediatric AIDS Clinical Trials Group Protocol 377.

S. Hayashi, F. Aweeka, P. Krogstad, 2003, Pediatrics.

Pharmacokinetic Characteristics of Ritonavir, Zidovudine, Lamivudine, and Stavudine in Children with Human Immunodeficiency Virus Infection

C. Fletcher, S. Pelton, R. Yogev, 2004, Pharmacotherapy.

Neuropsychological Functioning and Viral Load in Stable Antiretroviral Therapy-Experienced HIV-Infected Children

R. Jeremy, P. Krogstad, S. Pelton, 2005, Pediatrics.

Lack of Effect on Survival of High-Dose Acyclovir and Zidovudine Compared with Zidovudine Alone for Acquired Immunodeficiency Syndrome

A. Collier, L. Corey, D. Schoenfeld, 1998, Antiviral Therapy.

Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?

D. Spiegelman, A. Collier, M. Fischl, 2001, AIDS research and human retroviruses.

Design of Randomized Controlled Trials

Kenneth Stanley, K. Stanley, 2007, Circulation.

Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication

L. Mofenson, A. Scheuerle, L. Mandelbrot, 2011, Journal of perinatal medicine.

Hemodialysis infection prevention with polysporin ointment.

J. Hux, J. Conly, S. Tobe, 2003, Journal of the American Society of Nephrology : JASN.

Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial.

M. Tonelli, B. Hemmelgarn, L. Moist, 2012, JAMA.

Design of the fish oil inhibition of stenosis in hemodialysis grafts (FISH) study

M. Tonelli, B. Hemmelgarn, L. Moist, 2007, Clinical trials.

Baseline Resistance to Nucleoside Reverse Transcriptase Inhibitors Fails to Predict Virologic Response to Combination Therapy in Children (pactg 338)

L. Mofenson, Chengcheng Hu, S. Pelton, 2007 .

Stavudine, nevirapine and ritonavir in stable antiretroviral therapy-experienced children with human immunodeficiency virus infection.

L. Mofenson, S. Pelton, R. Yogev, 2002, The Pediatric infectious disease journal.

Baseline resistance to nucleoside reverse transcriptase inhibitors fails to predict virologic response to combination therapy in children (PACTG 338)

L. Mofenson, Chengcheng Hu, S. Pelton, 2007, AIDS Research and Therapy.

Baseline resistance to nucleoside reverse transcriptase inhibitors fails to predict virologic response to combination therapy in children (PACTG 338)

L. Mofenson, Chengcheng Hu, S. Pelton, 2007, AIDS research and therapy.